* To take the test online, go to our secure Web site at www.nursingcenter.com/ce/ajn.
* To use the form provided in this issue, record your answers in the test answer section of the CE enrollment form below. Each question has only one correct answer. You may make copies of the form.
* Complete the registration information and course evaluation. Mail the completed enrollment form and registration fee to: Lippincott Williams and Wilkins, CE Group, 74 Brick Blvd., Bldg. 4, Suite 206, Brick, NJ 08723. You will receive your certificate in four to six weeks. For faster service, include a fax number and we will fax your certificate within two business days of receiving your enrollment form. You will receive your CE certificate of earned contact hours and an answer key to review your results. There is no minimum passing grade.
* Registration deadline is October 31, 2014.
DISCOUNTS AND CUSTOMER SERVICE
* Send in together two or more tests from any nursing journal published by Lippincott, Williams and Wilkins (LWW), and deduct $0.95 from the price of each test.
* We also offer CE accounts for hospitals and other health care facilities online at www.nursingcenter.com. Call 1-800-787-8985 for details.
LWW, publisher of AJN, will award the number of contact hours indicated for each continuing nursing education activity. LWW is accredited as a provider of continuing nursing education by the Commission on Accreditation of the American Nurses Credentialing Center (ANCC).
These activities are also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for the number of contact hours indicated. LWW is also an approved provider of continuing nursing education by the District of Columbia and Florida #FBN2454. Your certificate is valid in all states.
The ANCC's accreditation status of the LWW Department of Continuing Education refers to its continuing nursing educational activities only and does not imply Commission on Accreditation approval or endorsement of any commercial product.
CE TEST QUESTIONS
To present registered professional nurses with the details of a study done to explore several characteristics of young women who tested positive for a BRCA gene mutation.
After reading this article and taking this test, you will be able to
* review the background information helpful in understanding the need for the author's study of young women who are BRCA positive.
* outline the research presented here that is relevant for young women who are BRCA positive.
* summarize the results of the author's study of young women who are BRCA positive.
1. If one parent has a BRCA gene mutation, what chance does each offspring have of inheriting it?
2. In addition to breast cancer, a mutation in BRCA2 increases the risk of which other type of cancer?
3. Compared with women who have the BRCA mutation and therefore a breast cancer risk of 50% to 85% by age 50, women who do not have the mutation have a breast cancer risk of
4. The National Comprehensive Cancer Network (NCCN) suggests testing for hereditary breast and ovarian cancer risk in any woman who has a
a. breast cancer diagnosis before age 45.
b. breast cancer diagnosis before age 50.
c. first-degree relative with the diagnosis before age 55.
d. first-degree relative with the diagnosis before age 60.
5. For a woman who tests positive for a BRCA1 or BRCA2 gene mutation, the NCCN suggests mammography alternating with
c. magnetic resonance imaging.
d. computed tomography.
6. Being BRCA positive at a younger age is associated with
a. decreased urgency in life partnering.
b. increased urgency in childbearing.
c. lower cancer-specific anxiety.
d. lower perceptions of stigma.
7. Of the 44 women who participated in the author's study, the largest percentage was
c. living with a partner.
d. living with a same-sex partner.
8. Many of the study participants who had children identified which of the following as their primary goal related to their children?
a. telling them about the mutation
b. staying alive for them
c. managing their own care
d. testing them for the mutation
9. Participants with children tended to
a. regret the choice to have children.
b. focus on believing that their children were not at risk.
c. wish they'd had genetic testing much earlier in life.
d. move quickly in getting a prophylactic mastectomy.
10. Participants said that the BRCA mutation became more of a focus
a. upon diagnosis of breast cancer.
b. when making treatment choices.
c. during breast cancer treatment.
d. after breast cancer treatment ended.
11. Some of the married participants in this study identified a sense of
a. doubt that preventive services are effective.
b. worry about the survival of their marriage.
c. being less than “perfect” to family members.
d. needing financial support for the various treatment options.
12. The most recent meta-analysis of BRCA-positive women both with and without breast cancer found that using oral contraceptives formulated after 1975
a. had no associated risk of breast cancer development.
b. significantly increased the risk of breast cancer development.
c. slightly increased the risk of breast cancer development.
d. slightly decreased the risk of breast cancer development.
13. Recent data show that women with a BRCA1 or BRCA2 mutation who use oral contraceptives have a reduced risk of ovarian cancer of about
14. The American Association of Colleges of Nursing in the 2008 Essentials of Baccalaureate Education for Professional Nursing Practice included genetics and genomics as
a. a specialty of interest to some nurses.
b. information important to women's health nurses.
c. an area most nurses lack general knowledge about.
d. critical knowledge for practicing nurses.
15. In a recent survey, what percentage of baccalaureate programs did not meet the Essential Nursing Competencies and Curricula Guidelines for Genetics and Genomics?
16. Applying the Essential Nursing Competencies and Curricula Guidelines for Genetics and Genomics, the author advises that good nursing practice includes an awareness that young women with a BRCA mutation may seem
© 2012 Lippincott Williams & Wilkins, Inc.